133 related articles for article (PubMed ID: 32352232)
1. Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer.
Saidy B; Rakha EA; Green AR; Ellis IO; Martin SG; Storr SJ
J Cell Mol Med; 2020 Jun; 24(11):6263-6271. PubMed ID: 32352232
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and cAMP-regulated phosphoprotein 32kDa (DARPP-32), protein phosphatase-1 and cyclin-dependent kinase 5 expression in ovarian cancer.
Martin SG; Zhang S; Yang S; Saidy B; Deen S; Storr SJ
J Cell Mol Med; 2020 Aug; 24(16):9165-9175. PubMed ID: 32588513
[TBL] [Abstract][Full Text] [Related]
3. Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.
Kotecha S; Lebot MN; Sukkarn B; Ball G; Moseley PM; Chan SY; Green AR; Rakha E; Ellis IO; Martin SG; Storr SJ
Sci Rep; 2019 Nov; 9(1):16987. PubMed ID: 31740718
[TBL] [Abstract][Full Text] [Related]
4. PP1, PKA and DARPP-32 in breast cancer: A retrospective assessment of protein and mRNA expression.
Saidy B; Kotecha S; Butler A; Rakha EA; Ellis IO; Green AR; Martin SG; Storr SJ
J Cell Mol Med; 2021 Jun; 25(11):5015-5024. PubMed ID: 33991172
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 5 decreases in gastric cancer and its nuclear accumulation suppresses gastric tumorigenesis.
Cao L; Zhou J; Zhang J; Wu S; Yang X; Zhao X; Li H; Luo M; Yu Q; Lin G; Lin H; Xie J; Li P; Hu X; Zheng C; Bu G; Zhang YW; Xu H; Yang Y; Huang C; Zhang J
Clin Cancer Res; 2015 Mar; 21(6):1419-28. PubMed ID: 25609066
[TBL] [Abstract][Full Text] [Related]
6. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
7. A kinase of many talents: non-neuronal functions of CDK5 in development and disease.
Sharma S; Sicinski P
Open Biol; 2020 Jan; 10(1):190287. PubMed ID: 31910742
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
10. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
Zheng M; Leung CL; Liem RK
J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970
[TBL] [Abstract][Full Text] [Related]
11. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.
Asada A; Yamamoto N; Gohda M; Saito T; Hayashi N; Hisanaga S
J Neurochem; 2008 Aug; 106(3):1325-36. PubMed ID: 18507738
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.
Odemuyiwa SO; Ilarraza R; Davoine F; Logan MR; Shayeganpour A; Wu Y; Majaesic C; Adamko DJ; Moqbel R; Lacy P
Immunology; 2015 Apr; 144(4):641-8. PubMed ID: 25346443
[TBL] [Abstract][Full Text] [Related]
14. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
[TBL] [Abstract][Full Text] [Related]
16. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
17. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma.
Zhu L; Ding R; Zhang J; Zhang J; Lin Z
BMC Cancer; 2019 Jul; 19(1):698. PubMed ID: 31311512
[TBL] [Abstract][Full Text] [Related]
19. Cyclin I and p35 determine the subcellular distribution of Cdk5.
Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT
Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the Cdk5-dependent phosphorylation sites of inhibitor-1 and DARPP-32 by depolarization.
Nguyen C; Hosokawa T; Kuroiwa M; Ip NY; Nishi A; Hisanaga S; Bibb JA
J Neurochem; 2007 Nov; 103(4):1582-93. PubMed ID: 17868322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
